05.12.22
Global life science company Bioiberica has added two branded ingredients to its portfolio: DAOgest for digestive health and Dermial for skin and beauty.
The launches form part of Bioiberica’s mission to empower nutraceutical brands to innovate in the evolving healthcare market by creating future-facing solutions for the growing skin and beauty, digestive and joint health categories.
“Histamine intolerance affects an estimated 1-3% of the global population, causing them to experience allergy-like symptoms after consuming histamine rich foods,” said Jaume Reguant, Healthcare Director at Bioiberica.
Until now, the market opportunities around this condition have remained largely unmet. That’s why Bioiberica developed DAOgest, a digestive health supplement ingredient, which provides diamine oxidase (DAO) enzyme to improve histamine digestion. A natural extract, the solution can provide an immediate effect at a low dose of 4.2 mg/serving, according to the company.
“We’re calling on our industry partners to join forces with us in our goal to develop long-term health solutions that will improve lives for generations to come,” said Reguant. “With DAOgest, we’re giving manufacturers the opportunity to do just that—to create finished dosage forms that have the power to enable those suffering with this digestive condition to enjoy their favorite foods and drinks.”
The nutricosmetics market is witnessing exponential growth, with today’s health-conscious consumers seeking solutions that support beauty-from-within. For formulators exploring new product developments in this space, Bioiberica introduces Dermial, the first hyaluronic acid matrix ingredient of its kind. Designed to power innovation in dietary supplements, functional foods and nutricosmetics, it is easy to formulate at a low daily dose (60 mg) and exhibits excellent organoleptic properties, the company claimed.
Harnessing Bioiberica’s scientific research and expertise in glycosaminoglycans, Dermial contains a combination of three naturally-occurring components: hyaluronic acid, glycosaminoglycans (including dermatan and chondroitin sulfate), and hydrolysed collagen.
Demonstrated by scientific studies, this unique composition has been shown to elicit superior results when compared to microbial fermentation origin hyaluronic acid, including increased in vitro production of type I collagen by 48%.
The launches form part of Bioiberica’s mission to empower nutraceutical brands to innovate in the evolving healthcare market by creating future-facing solutions for the growing skin and beauty, digestive and joint health categories.
“Histamine intolerance affects an estimated 1-3% of the global population, causing them to experience allergy-like symptoms after consuming histamine rich foods,” said Jaume Reguant, Healthcare Director at Bioiberica.
Until now, the market opportunities around this condition have remained largely unmet. That’s why Bioiberica developed DAOgest, a digestive health supplement ingredient, which provides diamine oxidase (DAO) enzyme to improve histamine digestion. A natural extract, the solution can provide an immediate effect at a low dose of 4.2 mg/serving, according to the company.
“We’re calling on our industry partners to join forces with us in our goal to develop long-term health solutions that will improve lives for generations to come,” said Reguant. “With DAOgest, we’re giving manufacturers the opportunity to do just that—to create finished dosage forms that have the power to enable those suffering with this digestive condition to enjoy their favorite foods and drinks.”
The nutricosmetics market is witnessing exponential growth, with today’s health-conscious consumers seeking solutions that support beauty-from-within. For formulators exploring new product developments in this space, Bioiberica introduces Dermial, the first hyaluronic acid matrix ingredient of its kind. Designed to power innovation in dietary supplements, functional foods and nutricosmetics, it is easy to formulate at a low daily dose (60 mg) and exhibits excellent organoleptic properties, the company claimed.
Harnessing Bioiberica’s scientific research and expertise in glycosaminoglycans, Dermial contains a combination of three naturally-occurring components: hyaluronic acid, glycosaminoglycans (including dermatan and chondroitin sulfate), and hydrolysed collagen.
Demonstrated by scientific studies, this unique composition has been shown to elicit superior results when compared to microbial fermentation origin hyaluronic acid, including increased in vitro production of type I collagen by 48%.
